These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 11230007)
21. Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia. Brecher M; Leong RW; Stening G; Osterling-Koskinen L; Jones AM J Clin Psychiatry; 2007 Apr; 68(4):597-603. PubMed ID: 17474816 [TBL] [Abstract][Full Text] [Related]
22. Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine. Kluge M; Dietzel J Psychiatry Clin Neurosci; 2013 Apr; 67(3):189-90. PubMed ID: 23581871 [No Abstract] [Full Text] [Related]
23. FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia. Traynor K Am J Health Syst Pharm; 2009 May; 66(10):880, 882. PubMed ID: 19420301 [No Abstract] [Full Text] [Related]
24. A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders. Schimmelmann BG; Mehler-Wex C; Lambert M; Schulze-zur-Wiesch C; Koch E; Flechtner HH; Gierow B; Maier J; Meyer E; Schulte-Markwort M J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):768-78. PubMed ID: 18315449 [TBL] [Abstract][Full Text] [Related]
25. Intranasal quetiapine abuse. Pierre JM; Shnayder I; Wirshing DA; Wirshing WC Am J Psychiatry; 2004 Sep; 161(9):1718. PubMed ID: 15337673 [No Abstract] [Full Text] [Related]
26. Quetiapine for schizophrenia. Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044 [No Abstract] [Full Text] [Related]
27. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia. Nasrallah HA; Tandon R J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142 [TBL] [Abstract][Full Text] [Related]
28. Weight gain induced with olanzapine in adolescent. Graovac M; Ružić K; Rebić J; Dadić-Hero E; Kaštelan A; Frančišković T Psychiatr Danub; 2011 Mar; 23(1):101-4. PubMed ID: 21448109 [TBL] [Abstract][Full Text] [Related]
29. [Quetiapine in the treatment of acute mania]. Bräunig P Psychiatr Prax; 2006 Mar; 33 Suppl 1():S27-31. PubMed ID: 16511728 [TBL] [Abstract][Full Text] [Related]
31. Diabetes and atypical neuroleptics. Geller WK; MacFadden W Am J Psychiatry; 2003 Feb; 160(2):388; author reply 389. PubMed ID: 12562601 [No Abstract] [Full Text] [Related]
32. Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients. Rasmussen H; Ebdrup BH; Oranje B; Pinborg LH; Knudsen GM; Glenthøj B Int J Neuropsychopharmacol; 2014 Nov; 17(11):1729-36. PubMed ID: 24830305 [TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder. Honer WG; MacEwan GW; Gendron A; Stip E; Labelle A; Williams R; Eriksson H; J Clin Psychiatry; 2012 Jan; 73(1):13-20. PubMed ID: 21733490 [TBL] [Abstract][Full Text] [Related]
34. Weight gain--as possible predictor of metabolic syndrome. Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110 [TBL] [Abstract][Full Text] [Related]